Viewing nowDapaflo 10 mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Boryung Biopharma Co., Ltd.

MFDS item code 202200991 · Approved 2022.03.10 · Insurance code 670502490
Improves blood glucose control in type 2 diabetes mellitus
This medication is used as an aid in the dietary and exercise regimen for controlling blood sugar in patients with type 2 diabetes. It can be used alone or in combination with other medications. It is particularly useful for patients whose blood sugar is not adequately controlled, especially those with cardiovascular diseases or risk factors, and it may help prevent cardiovascular events. This medication improves blood sugar management through effective treatment of type 2 diabetes.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this drug when administered in combination with metformin is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients undergoing dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, 5 mg is recommended as the starting dose. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This drug should not be used in certain patients. It should not be administered to those allergic to the active ingredient or additives, patients with type 1 diabetes, diabetic ketoacidosis, or those with lactose intolerance or related genetic disorders. Additionally, patients on dialysis should not take this medication. Patients with decreased fluid volume or impaired kidney function should use this medication with caution. This drug can lower blood pressure and reduce fluid volume in the blood, potentially leading to hypotension or kidney damage, so fluid status and kidney function should be carefully monitored before and after administration. The efficacy of this drug in controlling blood sugar varies with kidney function, and it may be less effective in patients with moderate or severe renal impairment. During administration, side effects such as genital infections, urinary tract infections, hypoglycemia, decreased fluid volume, and diabetic ketoacidosis may occur. Particularly, genital infections may be more common in women and patients with a history of infections, so caution is advised. When used in conjunction with blood glucose-lowering agents, there may be an increased risk of hypoglycemia, and dosage adjustments of insulin or sulfonylureas may be necessary. If symptoms of dehydration or hypotension due to decreased fluid volume occur, it is essential to consult a physician immediately, and the medication may need to be temporarily discontinued. Use during pregnancy is not recommended, and the medication should be stopped if pregnancy is confirmed. Breastfeeding women are also advised not to use this medication. Elderly patients or those with impaired kidney function should use it with special caution, and frequent blood tests and health assessments are required. During the course of taking this medication, regular blood sugar monitoring is essential, and caution should be exercised as some testing methods may be affected. There is no specific antidote in case of overdose, and appropriate treatment based on symptoms is necessary, with symptomatic management as advised by a physician. Finally, this medication has not been established for safety and efficacy in children, so it should not be used by this population. During treatment, patients should be cautious of hypoglycemic symptoms when driving or operating machinery and should consult a professional immediately if any unusual symptoms occur.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, elevated hematocrit, decreased creatinine clearance at the start of treatment, dyslipidemia, elevated serum creatinine at the start of treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempts, gastric adenocarcinoma, anaphylactic reaction, chest pain, chronic gastritis, diverticulosis, pneumoperitoneum, frequent bowel movements, gastroenteritis, colon polyps, bowel perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gingival disorders, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, hesitancy, urolithiasis, abnormal urination, increased blood lactate, lymphocytopenia, vitamin D deficiency, increased appetite, dysgeusia, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, nerve compression, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremors, bronchitis, herpes zoster, sinusitis, tonsillitis, herpes simplex, hordeolum, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, simplex herpes, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like syndrome, fatigue, chest discomfort, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, irregular menstruation, pruritus, urticaria, diaphoresis, arthralgia, musculoskeletal pain, limb pain, muscular weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius. Proper storage helps preserve the medication's effectiveness and safety.
Yellow, biconvex, diamond-shaped film-coated tablets
28 tablets (14 tablets/PTP×2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Boryung Biopharma Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.